This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Copay 2024 – Copay, Reimbursement and Access Congress
November 18-20, 2024
Hilton Penn’s LandingPhiladelphia, PA
Book Now
Menu
Book

Michael Ingham
Group Director, Market Access Scientific and External Strategy, Value & Evidence, Scientific Engagement at Janssen Scientific Affairs, LLC
Speaker

Profile

A seasoned health economics research professional with advanced degrees in Epidemiology and Health Policy, who specializes in Health Technology Assessment and Evidence-based Medicine frameworks, as well as Policy analysis and strategic implications. Worldwide experience from Canada, Europe and US. Has led both global and local health economics, early development and policy strategy.

A Canadian ex-pat currently residing in Doylestown, Pennsylvania.

Agenda Sessions

  • Leveraging Data to Understand the Impacts of Copay Adjustment Programs on Historically Marginalized Communities

    , 2:50pm
    View Session

At this event

Prev
Next
Bob Lahman
President, Three Boxer Consulting, Inc., Former Senior Vice President, Industry Relations, OptumRx
Three Boxer Consultancy, Inc.

See Michael at Copay 2024 – Copay, Reimbursement and Access Congress

Book Now